ARTICLE | Distillery Therapeutics
Pyrimidinol-based inhibitor of MAP4K4 for myocardial infarction
April 30, 2019 12:55 PM UTC
INDICATION: Myocardial infarction (MI)...
BCIQ Company Profiles
BCIQ Target Profiles
Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4) (MEKKK4)